Propanc Biopharma, Inc. was originally founded on October 15, 2007, in Melbourne, Victoria, Australia. On November 23, 2010, the company was re-registered in Delaware, USA. Currently in the development stage, Propanc Biopharma is a healthcare company focused on creating innovative cancer treatments for patients suffering from pancreatic, ovarian, and other forms of cancer. Leveraging the expertise of their scientific and oncology advisors, they have developed a carefully designed anti-cancer compound formulation, in which multiple compounds work synergistically to control or prevent tumor recurrence and metastasis in the body. Their leading candidate product, PRP, is a novel variation of this formulation and involves proenzymes—enzymes in their inactive precursor form. Company website: http://www.propanc.com Company address: 302 6 Butler Street Camberwell, VIC 3124 Australia

Complete your account application and verification in just 1 minute. The process is fully self-service and available on both RockFlow App and Web.

Once your account has been verified, you can deposit funds into your account using your preferred payment method.

Search for PPCB via RockFlow App or Web, enter the amount you want to invest, and tap Confirm to execute the trade.